Human NRXN3(Neurexin3) ELISA Kit – ATO8785
ATO8785
Size:Price:
48 T$320.00
96 T$458.00
Download

Overview

Product name: Human NRXN3(Neurexin3) ELISA Kit
Reactivity: Human
Alternative Names: NRXN3; Neurexin-3; Neurexin III-alpha; Neurexin-3-alpha; C14orf60; KIAA0743
Assay Type: Sandwich
Sensitivity: 12.7 pg/mL
Standard: 2000 pg/mL
Detection Range: 31.25-2000 pg/mL
Sample Type: serum, plasma and other biological fluids
Assay Length: 3.5h
Research Area: Autistic Disorder
Uniprot ID: Q9Y4C0
Test principle: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human NRXN3. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human NRXN3. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human NRXN3, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm 10nm. The concentration of Human NRXN3 in the samples is then determined by comparing the OD of the samples to the standard curve.

Standard curve

Concentration (pg/mL) OD Corrected OD
2000.00 2.136 2.047
1000.00 1.625 1.536
500.00 1.174 1.085
250.00 0.847 0.758
125.00 0.535 0.446
62.50 0.363 0.274
31.25 0.206 0.117
0.00 0.089 0.000

Precision

Intra-assay Precision (Precision within an assay):CV%<8%

Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.

Inter-assay Precision (Precision between assays):CV%<10%

Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.

Recovery

Matrices listed below were spiked with certain level of recombinant NRXN3 and the recovery rates were calculated by comparing the measured value to the expected amount of NRXN3 in samples.
Matrix Recovery range Average
serum(n=5) 80-95% 87%
EDTA plasma(n=5) 87-99% 93%
Heparin plasma(n=5) 87-99% 93%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of NRXN3 and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Matrix 1:2 1:4 1:8 1:16
serum(n=5) 86-93% 93-101% 86-97% 90-101%
EDTA plasma(n=5) 82-94% 85-96% 78-90% 91-99%
Heparin plasma(n=5) 85-97% 90-99% 82-101% 93-105%